Show simple item record

dc.contributor.authorWagner, Karl-Heinz
dc.contributor.authorShiels, Ryan G
dc.contributor.authorLang, Claudia Anna
dc.contributor.authorKhoei, Nazlisadat Seyed
dc.contributor.authorBulmer, Andrew C
dc.date.accessioned2019-06-19T13:08:40Z
dc.date.available2019-06-19T13:08:40Z
dc.date.issued2018
dc.identifier.issn1040-8363
dc.identifier.doi10.1080/10408363.2018.1428526
dc.identifier.urihttp://hdl.handle.net/10072/381018
dc.description.abstractHyperbilirubinemia is a well-known condition in the clinical setting; however, the causes of elevated serum bilirubin are diverse, as are the clinical ramifications of this condition. For example, diagnoses of individuals vary depending on whether they exhibit an unconjugated or conjugated hyperbilirubinemia. Diagnoses can include conditions of disordered bilirubin metabolism (Gilbert’s, Crigler-Najjar, Rotor, or Dubin-Johnson syndromes) or an acquired disease, including alcoholic/non-alcoholic fatty liver disease, hepatotropic hepatitis, cirrhosis, or hepato-biliary malignancy. Assessment of bilirubin concentrations is typically conducted as part of routine liver function testing. Mildly elevated total bilirubin with normal serum activities of liver transaminases, biliary damage markers, and red blood cell counts, however, may indicate the presence of Gilbert’s syndrome (GS), a benign condition that is present in 5–10% of the population. In this case, mildly elevated unconjugated bilirubin in GS is strongly associated with “reduced” prevalence of chronic diseases, particularly cardiovascular diseases (CVD) and type 2 diabetes mellitus (and associated risk factors), as well as CVD-related and all-cause mortality. These reports challenge the dogma that bilirubin is simply a potentially neurotoxic by-product of heme catabolism and emphasize the importance of understanding its potential beneficial physiologic and detrimental pathophysiologic effects, in order to appropriately consider bilirubin test results within the clinical laboratory setting. With this information, we hope to improve the understanding of disorders of bilirubin metabolism, emphasize the diagnostic importance of these conditions, and outline the potential impact GS may have on resistance to disease.
dc.description.peerreviewedYes
dc.languageEnglish
dc.publisherTaylor & Francis
dc.publisher.placeUnited Kingdom
dc.relation.ispartofpagefrom129
dc.relation.ispartofpageto139
dc.relation.ispartofissue2
dc.relation.ispartofjournalCritical Reviews in Clinical Laboratory Sciences
dc.relation.ispartofvolume55
dc.subject.fieldofresearchMedical and Health Sciences not elsewhere classified
dc.subject.fieldofresearchMedical and Health Sciences
dc.subject.fieldofresearchcode119999
dc.subject.fieldofresearchcode11
dc.titleDiagnostic criteria and contributors to Gilbert's syndrome
dc.typeJournal article
dc.type.descriptionC1 - Articles
dc.type.codeC - Journal Articles
dc.description.versionVersion of Record (VoR)
gro.rights.copyright© 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/Licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
gro.hasfulltextNo Full Text
gro.griffith.authorShiels, Ryan G.
gro.griffith.authorBulmer, Andrew C.


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record